Intellia Therapeutics, Inc. (NTLA) has 123 open-market insider trades by 27 insiders since 2016. Over the last six months insiders net sold $159K. The most active filer is John M. Leonard, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jean Francois Formela | Dir | — | 15 | $189.9M | 2022-06-14 |
| John M. Leonard | CEOPres | — | 17 | $54.9M | 2026-08-21 |
| Novartis Institutes for BioMedical Research, Inc. | 10% Owner | — | 2 | $32.9M | 2017-12-12 |
| Caribou Biosciences, Inc. | 10% Owner | — | 1 | $29.5M | 2018-01-29 |
| Laura Sepp-Lorenzino | CSOVP | — | 6 | $19.4M | 2025-01-03 |
| Jose E. Rivera | CLOVP | — | 13 | $9.8M | 2021-04-01 |
| Glenn Goddard | CFOVP | — | 6 | $9.0M | 2024-03-01 |
| Nessan Bermingham | CEOPres | — | 1 | $7.0M | 2017-12-08 |
| Temasek Holdings (Private) Ltd | 10% Owner | — | 1 | $5.4M | 2016-05-11 |
| Perry A. Karsen | Dir | — | 1 | $4.8M | 2020-12-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael P. Dube | CAO & VP | Sell | $23K | 2026-10-02 |
| John M. Leonard | CEO & President | Sell | $287K | 2026-08-20 |
| Edward J. Dulac III | CFO & VP | Sell | $91K | 2026-07-22 |
| Edward J. Dulac III | CFO & VP | Sell | $84K | 2026-07-02 |
| Michael P. Dube | CAO & VP | Sell | $44K | 2026-07-01 |
| James Basta | EVP & General Counsel | Sell | $17K |
Companies that share insiders with NTLA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-03-02 |
| Eliana Clark | EVP & Chief Technical Officer | Sell | $8K | 2026-03-02 |
| David Lebwohl | EVP & Chief Medical Officer | Sell | $110K | 2026-01-05 |
| John M. Leonard | President | Sell | $314K | 2026-01-05 |
| Fred E. Cohen | Director | Buy | $1.4M | 2026-01-05 |
| James Basta | EVP & General Counsel | Sell | $96K | 2026-01-05 |
| Eliana Clark | EVP & Chief Technical Officer | Sell | $88K | 2026-01-05 |
| Edward J. Dulac III | CFO & EVP | Sell | $59K | 2026-01-05 |
| Birgit C. Schultes | EVP & Chief Scientific Officer | Sell | $78K | 2026-01-05 |
| Michael P. Dube | VP & Chief Accounting Officer | Sell | $28K | 2026-01-05 |